Therapy Areas: Devices
Boston Scientific to acquire Valencia Technologies to expand overactive bladder portfolio
12 January 2026 - Medical technology company Boston Scientific Corporation (NYSE: BSX) announced on Monday that it has entered into a definitive agreement to acquire Valencia Technologies Corporation,...
EQT Life Sciences exits Vivasure Medical in EUR185m sale to Haemonetics
12 January 2026 - EQT Life Sciences, a part of Swedish private equity company EQT AB (STO: EQT), announced on Monday that it has exited Vivasure Medical Limited, an Ireland-based developer of percutan...
Saluda Medical secures CE certification for EVA Sensing Technology in Europe
8 January 2026 - Saluda Medical, Inc. (ASX: SLD), an American commercial-stage medical device company, said on Thursday that its next-generation EVA Sensing Technology has received CE certification fo...
Antin to acquire clinical trial equipment provider Emsere
8 January 2026 - Private equity firm Antin Infrastructure Partners (Euronext Paris:ANTIN) announced on Thursday that it has agreed to acquire Emsere from Dutch family investment platform Gryphion.Emse...
Legacy Healthcare's Cinainu gains US FDA approval to advance multi-regional Phase 3 trial in alopecia areata
7 January 2026 - Swiss biopharmaceutical company Legacy Healthcare announced on Tuesday that it is planning to advance its topical solution, Cinainu, into a multi-regional Phase 3 trial (RAAINBOW-2) f...
Hyphens Pharma licenses Cerapro skin cream to Louis Widmer for six European markets
5 January 2026 - Singapore-based specialty pharmaceutical and consumer healthcare group Hyphens Pharma International Limited (SGX: 1J5) said on Monday that it has licensed the commercialisation of its...